Inogen Begin Period Cash Flow vs Capital Expenditures Analysis

INGN Stock

USD 9.38 0.17 1.85%

Inogen financial indicator trend analysis is infinitely more than just investigating Inogen Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inogen Inc is a good investment. Please check the relationship between Inogen Begin Period Cash Flow and its Capital Expenditures accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Begin Period Cash Flow vs Capital Expenditures

Begin Period Cash Flow vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inogen Inc Begin Period Cash Flow account and Capital Expenditures. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Inogen's Begin Period Cash Flow and Capital Expenditures is 0.5. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Inogen Inc, assuming nothing else is changed. The correlation between historical values of Inogen's Begin Period Cash Flow and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Inogen Inc are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Begin Period Cash Flow i.e., Inogen's Begin Period Cash Flow and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.5

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Inogen Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Inogen operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Inogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

As of the 25th of November 2024, Selling General Administrative is likely to grow to about 79 M, while Tax Provision is likely to drop about 740 K.

	2021	2022	2023	2024 (projected)
Gross Profit	176.5M	153.5M	126.7M	116.2M
Total Revenue	358.0M	377.2M	315.7M	250.3M

Gross Profit Total Revenue

Inogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.46	0.65	0.91	0.99	0.6	0.9	-0.98	0.71	0.44	0.99	0.91	0.83	0.97	0.78	0.83	0.9	0.88	0.97	0.86	0.93	0.92	0.49	0.98	0.32	0.73
Short Long Term Debt Total	0.46		0.57	0.68	0.37	0.79	0.72	-0.33	0.02	-0.22	0.42	0.52	0.53	0.35	0.39	0.22	0.4	0.67	0.49	0.79	0.48	0.69	0.74	0.41	0.23	0.33
Other Current Liab	0.65	0.57		0.79	0.6	0.7	0.75	-0.57	-0.01	-0.24	0.62	0.6	0.57	0.6	0.63	0.66	0.79	0.64	0.6	0.65	0.75	0.73	0.87	0.64	0.26	0.4
Total Current Liabilities	0.91	0.68	0.79		0.85	0.82	0.98	-0.82	0.41	0.2	0.87	0.86	0.85	0.82	0.82	0.78	0.87	0.9	0.89	0.9	0.92	0.98	0.71	0.87	0.27	0.63
Total Stockholder Equity	0.99	0.37	0.6	0.85		0.53	0.85	-0.99	0.76	0.51	0.99	0.87	0.78	0.99	0.77	0.84	0.89	0.82	0.96	0.81	0.91	0.86	0.41	0.99	0.36	0.7
Property Plant And Equipment Net	0.6	0.79	0.7	0.82	0.53		0.86	-0.46	0.02	-0.21	0.54	0.67	0.57	0.46	0.63	0.6	0.63	0.7	0.59	0.81	0.69	0.78	0.86	0.54	0.03	0.36
Current Deferred Revenue	0.9	0.72	0.75	0.98	0.85	0.86		-0.82	0.43	0.16	0.87	0.87	0.79	0.81	0.8	0.77	0.83	0.91	0.89	0.95	0.9	0.97	0.72	0.87	0.21	0.62
Net Debt	-0.98	-0.33	-0.57	-0.82	-0.99	-0.46	-0.82		-0.79	-0.55	-0.99	-0.82	-0.74	-1.0	-0.76	-0.83	-0.87	-0.78	-0.94	-0.77	-0.9	-0.82	-0.34	-0.99	-0.42	-0.66
Retained Earnings	0.71	0.02	-0.01	0.41	0.76	0.02	0.43	-0.79		0.78	0.75	0.59	0.5	0.77	0.36	0.47	0.46	0.51	0.67	0.48	0.52	0.47	-0.23	0.72	0.31	0.59
Accounts Payable	0.44	-0.22	-0.24	0.2	0.51	-0.21	0.16	-0.55	0.78		0.49	0.24	0.38	0.52	0.41	0.3	0.3	0.18	0.53	0.09	0.3	0.19	-0.41	0.51	0.43	0.22
Cash	0.99	0.42	0.62	0.87	0.99	0.54	0.87	-0.99	0.75	0.49		0.85	0.77	0.99	0.77	0.82	0.88	0.83	0.96	0.83	0.91	0.87	0.43	0.99	0.4	0.68
Non Current Assets Total	0.91	0.52	0.6	0.86	0.87	0.67	0.87	-0.82	0.59	0.24	0.85		0.87	0.8	0.59	0.69	0.74	0.96	0.85	0.88	0.8	0.93	0.53	0.82	-0.02	0.9
Non Currrent Assets Other	0.83	0.53	0.57	0.85	0.78	0.57	0.79	-0.74	0.5	0.38	0.77	0.87		0.73	0.61	0.57	0.72	0.87	0.84	0.74	0.74	0.89	0.49	0.76	0.18	0.78
Cash And Short Term Investments	0.97	0.35	0.6	0.82	0.99	0.46	0.81	-1.0	0.77	0.52	0.99	0.8	0.73		0.75	0.83	0.88	0.77	0.94	0.77	0.9	0.82	0.36	0.99	0.47	0.63
Net Receivables	0.78	0.39	0.63	0.82	0.77	0.63	0.8	-0.76	0.36	0.41	0.77	0.59	0.61	0.75		0.83	0.87	0.6	0.84	0.62	0.87	0.73	0.54	0.82	0.4	0.26
Common Stock Total Equity	0.83	0.22	0.66	0.78	0.84	0.6	0.77	-0.83	0.47	0.3	0.82	0.69	0.57	0.83	0.83		0.91	0.62	0.79	0.62	0.92	0.72	0.48	0.85	0.24	0.45
Common Stock Shares Outstanding	0.9	0.4	0.79	0.87	0.89	0.63	0.83	-0.87	0.46	0.3	0.88	0.74	0.72	0.88	0.87	0.91		0.71	0.88	0.69	0.97	0.81	0.61	0.91	0.42	0.5
Non Current Liabilities Total	0.88	0.67	0.64	0.9	0.82	0.7	0.91	-0.78	0.51	0.18	0.83	0.96	0.87	0.77	0.6	0.62	0.71		0.85	0.93	0.8	0.98	0.58	0.8	0.03	0.87
Inventory	0.97	0.49	0.6	0.89	0.96	0.59	0.89	-0.94	0.67	0.53	0.96	0.85	0.84	0.94	0.84	0.79	0.88	0.85		0.82	0.91	0.89	0.49	0.97	0.38	0.65
Other Current Assets	0.86	0.79	0.65	0.9	0.81	0.81	0.95	-0.77	0.48	0.09	0.83	0.88	0.74	0.77	0.62	0.62	0.69	0.93	0.82		0.79	0.93	0.67	0.8	0.15	0.69
Other Stockholder Equity	0.93	0.48	0.75	0.92	0.91	0.69	0.9	-0.9	0.52	0.3	0.91	0.8	0.74	0.9	0.87	0.92	0.97	0.8	0.91	0.79		0.89	0.58	0.93	0.34	0.57
Total Liab	0.92	0.69	0.73	0.98	0.86	0.78	0.97	-0.82	0.47	0.19	0.87	0.93	0.89	0.82	0.73	0.72	0.81	0.98	0.89	0.93	0.89		0.66	0.86	0.16	0.77
Property Plant And Equipment Gross	0.49	0.74	0.87	0.71	0.41	0.86	0.72	-0.34	-0.23	-0.41	0.43	0.53	0.49	0.36	0.54	0.48	0.61	0.58	0.49	0.67	0.58	0.66		0.44	0.07	0.27
Total Current Assets	0.98	0.41	0.64	0.87	0.99	0.54	0.87	-0.99	0.72	0.51	0.99	0.82	0.76	0.99	0.82	0.85	0.91	0.8	0.97	0.8	0.93	0.86	0.44		0.45	0.62
Short Term Debt	0.32	0.23	0.26	0.27	0.36	0.03	0.21	-0.42	0.31	0.43	0.4	-0.02	0.18	0.47	0.4	0.24	0.42	0.03	0.38	0.15	0.34	0.16	0.07	0.45		-0.19
Intangible Assets	0.73	0.33	0.4	0.63	0.7	0.36	0.62	-0.66	0.59	0.22	0.68	0.9	0.78	0.63	0.26	0.45	0.5	0.87	0.65	0.69	0.57	0.77	0.27	0.62	-0.19

Click cells to compare fundamentals

Inogen Account Relationship Matchups

Inogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	447.3M	461.9M	489.5M	405.0M	326.2M	292.0M
Other Current Liab	12.0M	34.0M	35.8M	30.7M	60.9M	63.9M
Total Current Liabilities	50.2M	56.7M	61.5M	65.3M	72.5M	41.7M
Total Stockholder Equity	344.6M	349.6M	370.2M	297.4M	204.8M	222.6M
Property Plant And Equipment Net	25.3M	37.1M	63.8M	64.9M	70.7M	38.5M
Current Deferred Revenue	5.5M	7.0M	8.6M	8.9M	8.0M	4.7M
Net Debt	(191.3M)	(202.0M)	(208.9M)	(163.7M)	(103.6M)	(108.7M)
Retained Earnings	81.4M	75.6M	69.3M	(14.5M)	(116.9M)	(111.1M)
Accounts Payable	30.7M	12.5M	10.3M	18.2M	27K	25.7K
Cash	198.0M	212.0M	235.5M	187.0M	125.5M	130.8M
Non Current Assets Total	155.1M	156.2M	160.3M	100.4M	119.1M	87.1M
Non Currrent Assets Other	4.9M	2.7M	3.4M	2.4M	3.8M	2.0M
Cash And Short Term Investments	209.1M	231.2M	245.5M	187.0M	128.5M	144.0M
Net Receivables	37.3M	31.8M	25.8M	64.4M	42.2M	31.3M
Common Stock Shares Outstanding	22.2M	22.0M	22.5M	22.9M	23.2M	22.7M
Liabilities And Stockholders Equity	447.3M	461.9M	489.5M	405.0M	326.2M	292.0M
Non Current Liabilities Total	52.5M	55.5M	57.8M	42.3M	48.9M	27.6M
Inventory	35.7M	24.8M	31.9M	34.1M	21.8M	19.9M
Other Current Assets	10.2M	17.9M	26.0M	19.2M	14.5M	8.7M
Other Stockholder Equity	263.3M	273.5M	299.5M	312.1M	320.5M	203.3M
Total Liab	102.7M	112.2M	119.3M	107.6M	121.4M	69.4M
Property Plant And Equipment Gross	25.3M	37.1M	90.6M	95.1M	118.5M	124.4M
Total Current Assets	292.2M	305.7M	329.2M	304.6M	207.1M	204.8M
Accumulated Other Comprehensive Income	(87K)	475K	1.5M	(243K)	1.2M	1.3M
Short Term Debt	2.0M	1.9M	6.8M	7.0M	3.7M	5.5M
Intangible Assets	77.5M	68.8M	60.1M	177K	34.6M	21.3M
Other Liab	47.8M	47.4M	34.5M	22.5M	25.9M	20.4M
Other Assets	19.3M	17.1M	3.4M	2.4M	2.2M	2.1M
Property Plant Equipment	19.4M	28.2M	38.9M	43.3M	49.8M	31.0M
Net Tangible Assets	234.1M	247.7M	277.1M	264.4M	304.0M	242.1M
Good Will	33.0M	33.2M	33.0M	32.9M	10.1M	16.1M
Retained Earnings Total Equity	81.4M	75.6M	69.3M	(14.5M)	(16.7M)	(15.8M)
Short Term Investments	43.7M	11.1M	19.3M	10.0M	3.0M	2.8M
Deferred Long Term Liab	9.8M	232K	87K	25K	22.5K	21.4K
Capital Surpluse	263.3M	273.5M	299.5M	312.1M	358.9M	273.5M
Non Current Liabilities Other	52.5M	55.5M	57.8M	42.3M	48.6M	32.2M
Accumulated Depreciation	(44.9M)	(45.8M)	(51.7M)	(51.8M)	(46.7M)	(49.0M)

Pair Trading with Inogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Inogen Stock

0.63	VMD	Viemed Healthcare	Pair Corr
0.41	DOCS	Doximity	Pair Corr
0.37	FIGS	Figs Inc	Pair Corr
0.37	CVS	CVS Health Corp Aggressive Push	Pair Corr
0.36	SSY	SunLink Health Systems	Pair Corr

The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.

The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:

How To Invest In Inogen

Details

Is Inogen Stock a good investment?

Details

What is Inogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.873

Earnings Share

(2.25)

Revenue Per Share

14.095

Quarterly Revenue Growth

0.058

Return On Assets

(0.1)

The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Inogen Begin Period Cash Flow vs Capital Expenditures Analysis

Begin Period Cash Flow vs Capital Expenditures

Begin Period Cash Flow vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Capital Expenditures

Inogen fundamental ratios Correlations

Inogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Inogen fundamental ratios Accounts

Pair Trading with Inogen

Moving against Inogen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Assets
Cash	+ 0.99	Total Stockholder Equity
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Total Stockholder Equity
Cash And Short Term Investments	+ 0.99	Cash

Cash And Short Term Investments	- 1.0	Net Debt
Total Current Assets	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.98	Total Assets
Inventory	- 0.94	Net Debt